Fresenius Medical Care AG Places Bond with a Volume of 500 million Euros
Barclays Downgrades Fresenius Medical Care to Underweight
Fresenius Medical Care AG (FMS) (Q3 2026) Earnings Call Highlights: Stable Revenue, 5008X ...
Fresenius Medical Care AG 2026 Q3 - Results - Earnings Call Presentation
What Fresenius Medical Care AG & Co. KGaA (FMS) Said on Its Q3 Earnings Call
Fresenius Medical Care AG & Co. KGaA Q3 2026 Earnings Call Summary
Fresenius Medical Care AG Reports Q3 2026 Results and Narrows Full Year Outlook
Fresenius Medical Care AG (FMS) Q3 2026 Earnings Call Transcript
Fresenius Medical Care (XTRA:FME) Stock May Trade Below Fair Value On Its FDA Cleared AKI System Launch
Fresenius Medical Care reports third quarter 2026 performance partially offsetting headwinds and narrowing full year outlook
Fresenius Medical Care Q3 2026 Earnings Call Transcript
Fresenius Medical Care Affirms FY2026 Sales Guidance of $23.764B vs $22.490B Est
Fresenius Medical Care Q3 Adj. EPS $0.64 Flat Y/Y, Sales $5.682B vs $5.712B Year Ago
Reported Earlier, Fresenius Medical Care Launches multiFiltratePRO In US After FDA Clearance, Expanding Continuous Kidney Replacement Therapy Options For Acute Kidney Injury
Fresenius Medical Care Brings Kidney Care Innovation to Critical Care Patients with U.S. Launch of multiFiltratePRO™
Fresenius Medical Care presents new evidence and innovations advancing kidney care at ASN Kidney Week 2026
Truist Securities Maintains Hold on Fresenius Medical Care, Lowers Price Target to $24
Shervin J. Korangy appointed CEO of Fresenius Medical Care to lead the next phase of strategic development and long-term profitable growth
Fresenius Medical Care Appoints Shervin J. Korangy As CEO Effective October 12; Shervin J. Korangy To Succeed Helen Giza
Fresenius Medical Care: Margin Expansion Supports The Story, But Growth Remains Limited
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.